Evidence map›Paper›PMID 18642969›Full record

ReviewTechnology in cancer research & treatment2008

Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Zheng Huang, Heping Xu, Arlen D Meyers, Ali I Musani, Luowei Wang, Randall Tagg, Al B Barqawi, Yang K Chen

Open access · greenAbstract readReview
In one paragraph

Review in Technology in cancer research & treatment, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 328 citations in OpenAlex.

  1. Article
  2. Review
  3. Photodynamic Therapy in Dermatology.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Singlet Oxygen in Photodynamic Therapy.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Zheng HuangUniversity of Colorado Denver, Aurora Campus, CO, USA. zheng_huang@msn.com
Heping Xu
Arlen D Meyers
Ali I Musani
Luowei Wang
Randall Tagg
Al B Barqawi
Yang K Chen
University of Colorado Denver · USSecond Military Medical University · CNThunder Bay Regional Health Sciences Centre · CA

Funding

VERTERINARY PROJECTP01CA043892 · NCI · UNIVERSITY OF COLORADO DENVER · PI HETZEL, FRED W · 1987 to 2008
$9.9M
NCI NIH HHS CA43892NCI NIH HHS P01 CA043892
6 · The paper itself

Abstract

Photodynamic therapy (PDT) involves the administration of photosensitizer followed by local illumination with visible light of specific wavelength(s). In the presence of oxygen molecules, the light illumination of photosensitizer can lead to a series of photochemical reactions and consequently the generation of cytotoxic species. The quantity and location of PDT-induced cytotoxic species determine the nature and consequence of PDT. Much progress has been seen in both basic research and clinical application in recent years. Although the majority of approved PDT clinical protocols have primarily been used for the treatment of superficial lesions of both malignant and non-malignant diseases, interstitial PDT for the ablation of deep-seated solid tumors are now being investigated worldwide. The complexity of the geometry and non-homogeneity of solid tumor pose a great challenge on the implementation of minimally invasive interstitial PDT and the estimation of PDT dosimetry. This review will discuss the recent progress and technical challenges of various forms of interstitial PDT for the treatment of parenchymal and/or stromal tissues of solid tumors.

Indexed as

ApoptosisClinical Trials as TopicHumansImmune SystemLightMedical OncologyModels, StatisticalNeoplasmsOxygenPhotochemotherapyPhotosensitizing AgentsRadiometryOxygenPhotosensitizing Agents

Identifiers

PMID18642969
PMCPMC2593637
OpenAlexW2069451956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.